Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:developedBy |
gptkb:Magenta_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
MGTA-117
|
| gptkbp:indication |
gptkb:acute_myeloid_leukemia
myelodysplastic syndrome |
| gptkbp:intendedUse |
conditioning agent for stem cell transplantation
|
| gptkbp:mechanismOfAction |
antibody-drug conjugate targeting CD117 (c-Kit)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:CD117
|
| gptkbp:therapeuticArea |
hematopoietic stem cell transplantation
|
| gptkbp:bfsParent |
gptkb:Magenta_Therapeutics
|
| gptkbp:bfsLayer |
6
|